Organization · Venture Capital
Longevity Venture Partners
Longevity Venture Partners is an early-stage venture capital fund based in Israel, focusing on investments in the Silvertech, Healthcare, and Wellness sectors. The fund aims to enhance the quality of life for the aging population by supporting innovative startups.
Overview
What Longevity Venture Partners does
What Longevity Venture Partners is
Longevity Venture Partners is an early-stage venture capital fund based in Israel, focusing on investments in the Silvertech, Healthcare, and Wellness sectors. The fund aims to enhance the quality of life for the aging population by supporting innovative startups.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 28, 2026
Official channels
Find Longevity Venture Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Longevity Venture Partners as a funder
Investment thesis
Longevity Venture Partners focuses on early-stage technologies that enhance the quality of life, independence, and health outcomes for older adults, particularly in the Silvertech, Healthcare, and Wellness sectors.
Focus narrative
The fund focuses on early-stage investments in the Silvertech, Healthcare, and Wellness sectors. Longevity Venture Partners aims to create a commercial ecosystem that supports portfolio companies in testing, validating, and refining their value propositions, particularly for scaling in the U.S. market. By collaborating with corporate investors like CommuniCare, the fund enhances the commercialization potential of its investments.
Value beyond capital
Longevity Venture Partners adds value to its portfolio companies by providing access to a robust commercialization ecosystem, including partnerships with corporate investors. This network facilitates pilot programs, validation processes, and potential customer relationships, particularly in the U.S. healthcare market, enabling companies to refine their offerings and scale effectively.
Focus and fit
- Stages
- Seed · Series A
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Longevity Venture Partners has invested in several notable companies, including CustoMED, which focuses on innovative healthcare solutions; Sensifai Health, which applies wearable data to clinical relevance; and Exero Medical, known for its pivotal clinical trials in post-operative care. Other portfolio companies include Carefam, Lembas, OutSense, Behavidence, Carefull, FertilAI, and Voxela, each contributing to advancements in health and wellness for the aging population.
Common questions
What to know about Longevity Venture Partners
Upseed classifies Longevity Venture Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.